Prof. Oren Shriki
EEG, once confined to hospitals, is now coming home. Thanks to new FDA-cleared devices, lightweight EEG headbands now allow for comfortable brain monitoring—and they're opening new frontiers in epilepsy care, sleep medicine, and even athletic performance.
In 2024, Zeto's wireless headset received FDA clearance for use in homes, ambulances, and hospitals alike. Dreem 3S, another wearable sleep EEG device, has been validated for remote, technician-free use.
These devices represent a shift from snapshot diagnostics (only during hospital admissions) to continuous, real-world monitoring.
But not all EEG headsets are created equal. Epiness™, developed at NeuroHelp, combines clinical-grade EEG recordings with unmatched usability:
While other systems may require complex setups, or use fewer electrodes (sacrificing accuracy, and limiting the data for healthcare providers), Epiness strikes the perfect balance between signal quality and user compliance. This design was guided by research published in Sensors (2023), showing that 8 strategically placed electrodes maintain high seizure detection accuracy.
The global wearable EEG market is expanding fast and projected to grow from $285 million in 2023 to over $895 million by 2032, with major drivers including telemedicine, sleep health, and at-home epilepsy care Globe Newswire.
For epilepsy patients, Epiness offers a clinically meaningful way to continuously track and predict seizures during sleep and wakefulness. For athletes or sleep-conscious users, it provides true brain-based sleep stage monitoring—going beyond wrist-based estimations.
As EEG wearables become household health tools, NeuroHelp is leading the way with a solution that is both smart and simple—transforming how we understand and protect the brain.